최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Clinica chimica acta, v.455, 2016년, pp.202 - 208
Taylor, S.W. , Clarke, N.J. , Chen, Z. , McPhaul, M.J.
Background: Measurements of fasting levels of insulin and C-peptide are useful in documenting insulin resistance and may help predict development of diabetes mellitus. However, the specific insulin and C-peptide levels associated with specific degrees of insulin resistance have not been defined, owi...
Diabetes Metab. Res. Rev. Wang 26 378 2010 10.1002/dmrr.1089 Incidence rates and predictors of diabetes in those with prediabetes: the Strong Heart Study
Endocr. Pract. Johnson 16 47 2010 10.4158/EP09031.OR Identifying prediabetes using fasting insulin levels
Cardiovasc. Diabetol. Sung 10 108 2011 10.1186/1475-2840-10-108 Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up study
Diabetes Care Dankner 32 1464 2009 10.2337/dc09-0153 Basal-state hyperinsulinemia in healthy normoglycemic adults is predictive of type 2 diabetes over a 24-year follow-up: a preliminary report
Diabetes Metab. Res. Rev. Dankner 28 618 2012 10.1002/dmrr.2322 Basal state hyperinsulinemia in healthy normoglycemic adults heralds dysglycemia after more than two decades of follow up
Clin. Chem. Manley 53 922 2007 10.1373/clinchem.2006.077784 Comparison of 11 human insulin assays: implications for clinical investigation and research
Clin. Chem. Marcovina 53 711 2007 10.1373/clinchem.2006.082214 Standardization of insulin immunoassays: report of the American Diabetes Association workgroup
BMJ Stratton 321 405 2000 10.1136/bmj.321.7258.405 Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
Clin. Chem. Chen 59 1349 2013 10.1373/clinchem.2012.199794 Quantitative insulin analysis using liquid chromatography-tandem mass spectrometry in a high-throughput clinical laboratory
Anal. Chem. Chambers 86 694 2014 10.1021/ac403055d Multidimensional LC-MS/MS enables simultaneous quantification of intact human insulin and five recombinant analogs in human plasma
Proteomics Peterman 14 1445 2014 10.1002/pmic.201300300 An automated, high-throughput method for targeted quantification of intact insulin and its therapeutic analogs in human serum or plasma coupling mass spectrometric immunoassay with high resolution and accurate mass detection (MSIA-HR/AM)
Drug Test Anal. Thomas 6 1125 2014 10.1002/dta.1710 Determination of human insulin and its analogues in human blood using liquid chromatography coupled to ion mobility mass spectrometry (LC-IM-MS)
Clin. Chem. Cabaleiro 52 1193 2006 10.1373/clinchem.2005.062505 Feasibility of standardization of serum C-peptide immunoassays with isotope-dilution liquid chromatography-tandem mass spectrometry
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. Kinumi 953-954 138 2014 10.1016/j.jchromb.2014.02.019 Quantification of serum C-peptide by isotope-dilution liquid chromatography-tandem mass spectrometry: enhanced detection using chemical modification and immunoaffinity purification
Clin. Diagn. Lab. Immunol. Castro 7 197 2000 10.1128/CDLI.7.2.197-199.2000 Lipid removal from human serum samples
Clin. Chem. Lab. Med. Heurtault 52 355 2014 10.1515/cclm-2013-0427 Extensive study of human insulin immunoassays: promises and pitfalls for insulin analogue detection and quantification
J. Clin. Endocrinol. Metab. Cryer 94 709 2009 10.1210/jc.2008-1410 Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline
Bioanalysis Chambers 5 65 2013 10.4155/bio.12.290 Development of a fast method for direct analysis of intact synthetic insulins in human plasma: the large peptide challenge
Clin. Chem. Lab. Med. Haeckel 42 1069 2004 10.1515/CCLM.2004.215 Reference interval of serum insulin concentrations
Clin. Chem. Lab. Med. Schultess 47 834 2009 10.1515/CCLM.2009.185 Diagnostic performance of the ARCHITECT C-peptide immunoassay
Diabet. Med. Jones 30 803 2013 10.1111/dme.12159 The clinical utility of C-peptide measurement in the care of patients with diabetes
National Institute for Biological Standards and Control (NIBSC). C-peptide of human insulin, International Reference Reagent NIBSC code: 84/510. Instructions for use. Version 5.0. http://www.nibsc.org/documents/ifu/84-510.pdf. Updated December 2013. Accessed December 2015.
Medecine Nucleaire Van Uytfanghe 34 566 2010 10.1016/j.mednuc.2010.07.005 Standardization of insulin and C-peptide - a status report
※ AI-Helper는 부적절한 답변을 할 수 있습니다.